BFM
IMNM icon

Boothbay Fund Management’s Immunome IMNM Stock Holding History

Boothbay Fund Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Buy
+18,414
New +$394K 0.01% 1633

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Boothbay Fund Management's IMNM Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Immunome (IMNM) in Q2 2026: 18,414 shares worth $390K. The stake represents 0.01% of the portfolio and ranks #1633 among its holdings.

202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Boothbay Fund Management held 18,414 shares of Immunome worth $390K as of Q2 2026.
  • Immunome was a new Boothbay Fund Management position in Q2 2026.
  • Immunome made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1633 holding.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.